140 related articles for article (PubMed ID: 9089632)
1. The anti-cancer agent distamycin A displaces essential transcription factors and selectively inhibits myogenic differentiation.
Taylor A; Webster KA; Gustafson TA; Kedes L
Mol Cell Biochem; 1997 Apr; 169(1-2):61-72. PubMed ID: 9089632
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic agent doxorubicin inhibits myogenic differentiation of C2 myoblasts.
Kurabayashi M; Jeyaseelan R; Kedes L
J Biol Chem; 1993 Mar; 268(8):5524-9. PubMed ID: 8449915
[TBL] [Abstract][Full Text] [Related]
3. Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DR alpha gene.
Gambari R; Barbieri R; Nastruzzi C; Chiorboli V; Feriotto G; Natali PG; Giacomini P; Arcamone F
Biochem Pharmacol; 1991 Feb; 41(4):497-502. PubMed ID: 1997000
[TBL] [Abstract][Full Text] [Related]
4. Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements.
Broggini M; Ponti M; Ottolenghi S; D'Incalci M; Mongelli N; Mantovani R
Nucleic Acids Res; 1989 Feb; 17(3):1051-9. PubMed ID: 2922260
[TBL] [Abstract][Full Text] [Related]
5. Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter.
Ghersa P; Whelan J; Cambet Y; DeLamarter JF; Hooft van Huijsduijnen R
Nucleic Acids Res; 1997 Jan; 25(2):339-46. PubMed ID: 9016563
[TBL] [Abstract][Full Text] [Related]
6. Myogenic differentiation induces taurine transporter in association with taurine-mediated cytoprotection in skeletal muscles.
Uozumi Y; Ito T; Hoshino Y; Mohri T; Maeda M; Takahashi K; Fujio Y; Azuma J
Biochem J; 2006 Mar; 394(Pt 3):699-706. PubMed ID: 16318624
[TBL] [Abstract][Full Text] [Related]
7. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
Haider SR; Wang W; Kaufman SJ
Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
[TBL] [Abstract][Full Text] [Related]
8. Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1.
Sartorelli V; Webster KA; Kedes L
Genes Dev; 1990 Oct; 4(10):1811-22. PubMed ID: 2123467
[TBL] [Abstract][Full Text] [Related]
9. [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1.
Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Leoni A; Bianchi N; Feriotto G; Rutigliano C; Mischiati C; Gambari R
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1219-29. PubMed ID: 11097052
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of distamycin A against vaccinia virus is the result of inhibition of postreplicative mRNA synthesis.
Broyles SS; Kremer M; Knutson BA
J Virol; 2004 Feb; 78(4):2137-41. PubMed ID: 14747579
[TBL] [Abstract][Full Text] [Related]
11. Distamycin A selectively inhibits Acanthamoeba RNA synthesis and differentiation.
Orfeo T; Chen L; Huang W; Ward G; Bateman E
Biochim Biophys Acta; 1999 Sep; 1446(3):273-85. PubMed ID: 10524202
[TBL] [Abstract][Full Text] [Related]
12. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters.
Maeda T; Gupta MP; Stewart AF
Biochem Biophys Res Commun; 2002 Jun; 294(4):791-7. PubMed ID: 12061776
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD.
Friday BB; Mitchell PO; Kegley KM; Pavlath GK
Differentiation; 2003 Apr; 71(3):217-27. PubMed ID: 12694204
[TBL] [Abstract][Full Text] [Related]
14. A novel functional co-operation between MyoD, MEF2 and TRalpha1 is sufficient for the induction of GLUT4 gene transcription.
Santalucía T; Moreno H; Palacín M; Yacoub MH; Brand NJ; Zorzano A
J Mol Biol; 2001 Nov; 314(2):195-204. PubMed ID: 11718554
[TBL] [Abstract][Full Text] [Related]
15. Activation of the cardiac alpha-actin promoter depends upon serum response factor, Tinman homologue, Nkx-2.5, and intact serum response elements.
Chen CY; Croissant J; Majesky M; Topouzis S; McQuinn T; Frankovsky MJ; Schwartz RJ
Dev Genet; 1996; 19(2):119-30. PubMed ID: 8900044
[TBL] [Abstract][Full Text] [Related]
16. SV40 large T inhibits myogenic differentiation partially through inducing c-jun.
Endo T
J Biochem; 1992 Sep; 112(3):321-9. PubMed ID: 1331038
[TBL] [Abstract][Full Text] [Related]
17. Purkinje fibers of the avian heart express a myogenic transcription factor program distinct from cardiac and skeletal muscle.
Takebayashi-Suzuki K; Pauliks LB; Eltsefon Y; Mikawa T
Dev Biol; 2001 Jun; 234(2):390-401. PubMed ID: 11397008
[TBL] [Abstract][Full Text] [Related]
18. A competitive mechanism of CArG element regulation by YY1 and SRF: implications for assessment of Phox1/MHox transcription factor interactions at CArG elements.
Martin KA; Gualberto A; Kolman MF; Lowry J; Walsh K
DNA Cell Biol; 1997 May; 16(5):653-61. PubMed ID: 9174170
[TBL] [Abstract][Full Text] [Related]
19. An avian muscle factor related to MyoD1 activates muscle-specific promoters in nonmuscle cells of different germ-layer origin and in BrdU-treated myoblasts.
Lin ZY; Dechesne CA; Eldridge J; Paterson BM
Genes Dev; 1989 Jul; 3(7):986-96. PubMed ID: 2777078
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
